FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Dendreon | Provenge | cancer vaccine

Dendreon reveals Provenge data at AARC meeting

At the annual AARC meeting, Dendreon unveiled more Provenge data following the announcement of a successful trial last week. Researchers say Provenge induces long-term memory immune responses that are durable and can be maintained following boosting. Dendreon release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Dendreon   Provenge   cancer vaccine